Eli Lilly 2025 H1 ReportFinancial statementsEli Lilly's 2025 H1 revenue surged 41% to $28.29B, driven by tirzepatide sales hitting $14.7B. Mounjaro and Zepbound shine as blockbuster drugs, boosting Lilly's global pharmaceutical ranking.
Novo Nordisk H1 2025 Financial ReportsFinancial statementsNovo Nordisk's Semaglutide generated $16.7B in H1 2025, surpassing Keytruda as the world's top-selling drug. Strong global and China sales drive growth despite competitive challenges.
Pfizer 2025 H1 ReportFinancial statementsPfizer reported $28.4B in revenue for H1 2025, driven by $1.5B in ADC product sales and strong oncology growth. With $13B in BD firepower, Pfizer eyes long-term expansion across key therapeutic areas.
Huntsman 2025 Q2 ReportFinancial statementsHuntsman reports a $163M loss in H1 2025 and plans a global restructuring with 10% workforce cuts. Weak demand, high costs, and plant closures drive the chemical giant's cost-saving measures.
AstraZeneca 2025 H1 ResultsAstraZenecaAstraZeneca reports strong H1 2025 results with $28B in revenue. Oncology leads growth, driven by Enhertu, Tagrisso, and Truqap. R&D up 16%. Strong gains in CVRM, R&I, and rare diseases.
AbbVie 2025 H1 ReportAbbVieAbbVie reports strong H1 2025 results with $28.77B in revenue, driven by autoimmune leaders Skyrizi and Rinvoq. Oncology and neuroscience segments also show solid growth and strategic expansions.
GSK 2025 H1 PerformanceGSKGSK reports strong H1 2025 results with ￡15.5B revenue. Oncology grows 47%, HIV remains robust, and vaccines stay steady. Company targets ￡40B+ annual sales by 2031.
Sanofi 2025 h1 Performance SanofiSanofi reports strong 2025 H1 results with $21.8B revenue (+9.9%), driven by Dupixent sales hitting $8B and RSV antibody Beyfortus growing 79%. Rare disease drugs and BD deals also highlight growth momentum.
Axalta 2025 H1 PerformanceAxaltaAxalta reported H1 2025 revenue of $2.567B, down 2.95% YoY, with China sales up 9% to ￥2.1B. Strong Q2 profits driven by cost control and growth in mobility coatings despite lower volumes.
EN
Agricultural News
Food News
Industrial News
Cosmetic News
Pharmaceutical News
Science News
